Abstract
The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Current Pharmaceutical Design
Title:Dietary Intervention for Allergic Disease
Volume: 20 Issue: 6
Author(s): Yi Huang, Guansong Wang and Changzheng Wang
Affiliation:
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Abstract: The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Export Options
About this article
Cite this article as:
Huang Yi, Wang Guansong and Wang Changzheng, Dietary Intervention for Allergic Disease, Current Pharmaceutical Design 2014; 20 (6) . https://dx.doi.org/10.2174/13816128113199990049
DOI https://dx.doi.org/10.2174/13816128113199990049 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk
Current Molecular Pharmacology Dyslipidemia, Metabolic Syndrome and Vascular Disease Among Asian Indians
Vascular Disease Prevention (Discontinued) Atrial Macroreentry in Congenital Heart Disease
Current Cardiology Reviews Combination Therapy of Statins with Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now?
Current Pharmaceutical Design Clinical Observation of Liver Chemistry Abnormalities in Asthmatics
Current Drug Safety Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Current Cardiology Reviews Physiologic Tailoring of Treatment in Resistant Hypertension
Current Cardiology Reviews Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Targeting Vascular Redox Biology Through Antioxidant Gene Delivery: A Historical View and Current Perspectives
Recent Patents on Cardiovascular Drug Discovery The Effectiveness of Nurse- and Pharmacist-Directed Care in Diabetes Disease Management:A Narrative Review
Current Diabetes Reviews Biomarkers of Atrial Fibrillation in Metabolic Syndrome
Current Medicinal Chemistry Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Lifestyle Changes and Surgical Treatment for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Atherosclerotic Plaque Detection by Multi-detector Computed Tomography
Current Cardiology Reviews Predictive Factors of follow-up Non-attendance and Mortality Among Adults with Type 2 Diabetes Mellitus- an Analysis of the Malaysian Diabetes Registry 2009
Current Diabetes Reviews